Perspective Therapeutics
CATX3.0000.33% ( -0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Perspective Therapeutics(CATX) predict that the Revenue is 76 K (-77.78%), Miss estimate;the EBIT is -28.28 M (-29.54%), Beat estimate;the EPS is -0.25 (+0%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B77.78%
0.00B59.89%
-0.00B17.89%
EBITExceed expectations
-0.03B29.54%
-0.03B55.13%
+0.01B25.59%
EPSExceed expectations
-0.25--
-0.301320.53%
+0.051320.53%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 10, 2026
Estimate Revenue92.45 K
Estimate EBIT-30.5 M
Estimate EPS-0.2566
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf